Therapeutic Asset Ratings

6,308 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Begev Hodgkins Lymphoma	Fondazione Italiana Linfomi - ETS	P1/2	CCC (48)
Belantamab Mafodotin Hematologic Disorder	Hellenic Society of Hematology	P1/2	CCC (48)
Belantamab Mafodotin Plasma Cell Neoplasm	Hellenic Society of Hematology	P1/2	CCC (48)
Bendamustine Secondary Progressive Multiple Sclerosis	Tr1X, Inc.	P1/2	CCC (48)
Benserazide Beta-Thalassemia Intermedia	Phoenicia BioScience	P1/2	CCC (48)
BENZAMIDE, 3-((3-ENDO)-8-(2-((CYCLOHEXYLMETHYL)((2S)-2,3-DIHYDROXY-1-OXOPROPYL)AMINO)ETHYL)-8-AZABICYCLO(3.2.1)OCT-3-YL)- Cutaneous Melanoma	John Kirkwood	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Refractory Malignant Neoplasm	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Hypopharyngeal Carcinoma	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Laryngeal Carcinoma	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Lip Cancer	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Nasopharyngeal Carcinoma	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Oral Cavity Cancer	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Oropharynx Cancer	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Salivary Gland Cancer	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Tonsil Carcinoma	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Tracheal Cancer	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Head And Neck Carcinoma	VM Oncology, LLC	P1/2	CCC (48)
BENZOIC ACID, 4-((4-AMINO-3-(4-CYCLOHEXYL-1-PIPERAZINYL)-9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)- Salivary Gland Carcinoma	VM Oncology, LLC	P1/2	CCC (48)
BETAXOLOL Non-Hodgkin Lymphoma	Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd	P1/2	CCC (48)
Bet Bromodomain Inhibitor Zen-3694 Exocrine Pancreatic Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
Bexmarilimab Colon Carcinoma	Faron Pharmaceuticals Ltd	P1/2	CCC (48)
Bgb-16673 Diffuse Large B-Cell Lymphoma	BeiGene	P1/2	CCC (48)
bhb810 Colorectal Cancer	BigHat Biosciences, Inc.	P1/2	CCC (48)
bhb810 Gastroesophageal Junction Adenocarcinoma	BigHat Biosciences, Inc.	P1/2	CCC (48)
bhb810 Digestive System Cancer	BigHat Biosciences, Inc.	P1/2	CCC (48)

Showing 876 to 900 of 6,308 assets

PreviousPage 36 of 253Next